Data as of Jul 25, 2026 · Based on 2,718,867 AI responses across 9,511 prompts · See how Parse measures this
Nimbus Therapeuticsnimbustx.com · Low evidenceNimbus Therapeutics is a biotechnology company that designs and develops highly selective small molecule medicines for oncology, immunology, and metabolic indications. The company combines world-class expertise in computational drug design and translational medicine to create targeted therapies with exquisite selectivity.
Parse Score